Suppr超能文献

代谢组学分析揭示黄芪丹参汤对腺嘌呤诱导的大鼠慢性肾脏病的保护机制。

Metabolomics Analysis Reveals the Protection Mechanism of Huangqi-Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats.

作者信息

Liu Xinhui, Zhang Bing, Huang Shiying, Wang Fochang, Zheng Lin, Lu Jiandong, Zeng Youjia, Chen Jianping, Li Shunmin

机构信息

Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.

The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China.

出版信息

Front Pharmacol. 2019 Sep 10;10:992. doi: 10.3389/fphar.2019.00992. eCollection 2019.

Abstract

Huangqi-Danshen decoction (HDD) is a commonly used drug pair for clinical treatment of chronic kidney disease (CKD) in traditional Chinese medicine with good efficacy. However, the potential mechanisms of this action have not been well elucidated. The aim of this study was to explore the metabolic profiling variations in response to HDD treatment in a CKD rat model. CKD rat model was induced by adding 0.75% adenine to the diet for 4 weeks. The rats in the treatment group received HDD extract orally at the dose of 4.7 g/kg/day during the experiment. At the end of the experiment, serum and kidney samples were collected for biochemical and pathological examination. Ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS) was used to analyze metabolic profiling variations in the kidney. The results showed that treatment with HDD markedly attenuated kidney injury and improved renal function. A total of 28 metabolites contributing to CKD phenotype were found and identified in the kidney samples. The primary metabolic pathways disordered in the kidney of CKD rats were glycerophospholipid metabolism, glycosylphosphatidylinositol-anchor biosynthesis, and citrate cycle. Partial least squares discriminant analysis (PLS-DA) score plot showed that the three groups of renal samples were obviously divided into three categories, and the metabolic trajectory of the HDD treatment group moved to the control group. (E)-Piperolein A, phosphatidylcholines (PC) (18:1/22:6), phosphatidylinositols (PI) (13:0/18:1), PI (15:0/20:3), phosphatidylserines (PS) (O-20:0/12:0), and triglyceride (TG) (22:4/24:0/O-18:0) represented potential biomarkers of the renoprotective effects of HDD against CKD. In conclusion, HDD has renoprotective effect against adenine-induced CKD, which may be mediated partially restoration of perturbed metabolism in the kidney.

摘要

黄芪丹参汤(HDD)是中医临床治疗慢性肾脏病(CKD)常用的药对,疗效良好。然而,其作用的潜在机制尚未完全阐明。本研究旨在探讨CKD大鼠模型中HDD治疗后的代谢谱变化。通过在饮食中添加0.75%腺嘌呤4周诱导建立CKD大鼠模型。实验期间,治疗组大鼠以4.7 g/kg/天的剂量口服HDD提取物。实验结束时,收集血清和肾脏样本进行生化和病理检查。采用超高效液相色谱-四极杆飞行时间质谱联用仪(UHPLC-QTOF/MS)分析肾脏中的代谢谱变化。结果表明,HDD治疗显著减轻了肾脏损伤并改善了肾功能。在肾脏样本中发现并鉴定出28种导致CKD表型的代谢物。CKD大鼠肾脏中紊乱的主要代谢途径为甘油磷脂代谢、糖基磷脂酰肌醇锚定生物合成和柠檬酸循环。偏最小二乘判别分析(PLS-DA)得分图显示,三组肾脏样本明显分为三类,HDD治疗组的代谢轨迹向对照组移动。(E)-胡椒素A、磷脂酰胆碱(PC)(18:1/22:6)、磷脂酰肌醇(PI)(13:0/18:1)、PI(15:0/20:3)、磷脂酰丝氨酸(PS)(O-20:0/12:0)和甘油三酯(TG)(22:4/24:0/O-18:0)代表了HDD对CKD肾脏保护作用的潜在生物标志物。总之,HDD对腺嘌呤诱导的CKD具有肾脏保护作用,其机制可能部分是通过恢复肾脏中紊乱的代谢实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcac/6747014/3c6be5a24794/fphar-10-00992-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验